Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The Personalized Medicine project - how it started, the pitfalls and the benefits for clinicians and patients.

Dr Norbert Graf - Saarland University, Germany
The Personalized Medicine project - how it started, the pitfalls and the benefits for clinicians and patients. ( Dr Norbert Graf - Saarland University, Germany )
31 Jul 2013

The Personalized Medicine project and the Clinical Decision Support tool.

Dr Anca Bucur - Royal Philips Electronics, Netherlands
The Personalized Medicine project and the Clinical Decision Support tool. ( Dr Anca Bucur - Royal Philips Electronics, Netherlands )
31 Jul 2013

The Personalized Medicine project and improving user interfaces for clinicians and patients.

Dr Dieter Wallach - Ergosign, Germany
The Personalized Medicine project and improving user interfaces for clinicians and patients. ( Dr Dieter Wallach - Ergosign, Germany )
31 Jul 2013

Challenges and opportunities for implementing personalized medicine in Brazil

Dr Rui Reis - Barretos Cancer Hospital, Barretos, Brazil
Challenges and opportunities for implementing personalized medicine in Brazil ( Dr Rui Reis - Barretos Cancer Hospital, Barretos, Brazil )
19 Jul 2013

Biomarker analyses in emerging data from PI3K/AKT/mTOR programme clinical trials

Dr Anna Vivancos - Vall d´Hebron Institute of Oncology, Barcelona, Spain
Biomarker analyses in emerging data from PI3K/AKT/mTOR programme clinical trials ( Dr Anna Vivancos - Vall d´Hebron Institute of Oncology, Barcelona, Spain )
16 May 2013

Integrating breast cancer genomics and proteomics

Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA
Integrating breast cancer genomics and proteomics ( Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA )
15 May 2013

Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer

Dr Ivana Sestak - Queen Mary University of London, UK
Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer ( Dr Ivana Sestak - Queen Mary University of London, UK )
15 May 2013

CD4 T cells in extensively inflitrated breast cancer signal organised immune response and predict survival

Dr Karen Willard-Gallo - Université Libre de Bruxelles, Brussels, Belgium
CD4  T cells in extensively inflitrated breast cancer signal organised immune response and predict survival ( Dr Karen Willard-Gallo - Université Libre de Bruxelles, Brussels, Belgium )
15 May 2013

How do we design trials that improve outcome?

Dr Lisa Carey - University of North Carolina, Chapel Hill, USA
How do we design trials that improve outcome? ( Dr Lisa Carey - University of North Carolina, Chapel Hill, USA )
15 May 2013

Breast cancer heterogeneity no barrier to predictive testing

Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland
Breast cancer heterogeneity no barrier to predictive testing ( Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland )
15 May 2013

Single cell sequencing techniques in early and late breast cancer

Dr Nicholas Navin - MD Anderson Cancer Center, Houston, TX, USA
Single cell sequencing techniques in early and late breast cancer ( Dr Nicholas Navin - MD Anderson Cancer Center, Houston, TX, USA )
15 May 2013

Measurement variation influences gene expression profiles of breast cancer

Dr Rosanna Lau - MD Anderson Cancer Center, Houston, TX, USA
Measurement variation influences gene expression profiles of breast cancer ( Dr Rosanna Lau - MD Anderson Cancer Center, Houston, TX, USA )
15 May 2013